Narrative Review of Mesenchymal Stem Cell Therapy in Renal Diseases: Mechanisms, Clinical Applications, and Future Directions
2024

Mesenchymal Stem Cell Therapy for Kidney Diseases

publication Evidence: moderate

Author Information

Author(s): Wang Yanjun, Luo Pengli, Wuren Tan

Primary Institution: Qinghai University, Xining, China

Hypothesis

Can mesenchymal stem cells (MSCs) effectively treat renal diseases such as acute kidney injury (AKI) and chronic kidney disease (CKD)?

Conclusion

MSCs show promise in treating renal diseases by modulating immune responses and promoting tissue repair.

Supporting Evidence

  • MSCs can reduce inflammation and promote kidney repair.
  • Clinical trials show MSCs can improve kidney function in patients with lupus nephritis.
  • MSCs have the potential to enhance vascularization in chronic kidney disease.

Takeaway

This study looks at how special cells called mesenchymal stem cells can help fix problems in the kidneys, which are important for filtering our blood.

Methodology

The review analyzes existing research articles and clinical trials on MSCs in kidney therapy, focusing on their mechanisms and applications.

Potential Biases

Some studies lack randomized controls and sufficient blinding, which can affect the objectivity of outcomes.

Limitations

Animal models may not fully replicate human conditions, and many clinical trials have small sample sizes and short follow-up periods.

Digital Object Identifier (DOI)

10.1155/sci/8658246

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication